Related Experiment Video

Updated: Jun 6, 2026

Manufacture and Drug Delivery Applications of Silk Nanoparticles
09:03

Manufacture and Drug Delivery Applications of Silk Nanoparticles

Published on: October 8, 2016

Therapeutic Nanoparticles as Controlled Anti-Cancer Medications

G Z Chen1

  • 1Department of Hematology and Medical Oncology, Emory University School of Medicine and Winship Cancer Institute, Atlanta, GA, USA. gzchen@emory.edu.

Current Cancer Drug Targets
|December 17, 2010
PubMed

Insights

Therapeutic nanoparticles (TNPs) offer improved cancer treatment over traditional drugs by enhancing drug delivery and reducing toxicity. Further research is needed to fully understand TNP mechanisms for clinical application.

Area of Science:

  • Oncology
  • Nanotechnology
  • Drug Delivery

Background:

  • Therapeutic nanoparticles (TNPs) are increasingly researched for cancer treatment due to advantages over free chemotherapeutic drugs.
  • These advantages include enhanced solubility, tumor-specific accumulation, and improved antitumor efficacy with reduced systemic toxicity.
  • However, the precise mechanisms of TNP action and their clinical challenges remain incompletely understood.

Purpose of the Study:

  • To review and explore unresolved issues concerning the mechanisms of therapeutic nanoparticles in cancer treatment.
  • To compare the efficacy and toxicity of free drugs versus TNPs, and targeted versus non-targeted TNPs.
  • To discuss specific TNP characteristics and their applications in various cancer types.

Main Methods:

  • Literature review focusing on recent advancements in therapeutic nanoparticle research.
  • Comparative analysis of free drugs, targeted TNPs, and non-targeted TNPs.
  • Discussion of well-developed TNPs and their clinical relevance.

Main Results:

  • TNPs demonstrate significant potential for improved cancer therapy compared to conventional chemotherapy.
  • Understanding drug release, targeted delivery, and biodistribution is crucial for optimizing TNP efficacy and safety.
  • Specific TNP designs show promise for treating particular cancer types.

Conclusions:

  • Further elucidation of TNP mechanisms is essential for successful clinical translation.
  • Targeted TNPs offer a promising strategy to enhance cancer treatment outcomes.
  • Continued research into TNP characteristics and applications will advance oncology therapeutics.

More Related Videos

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases09:48

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases

Published on: August 23, 2024

Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery09:09

Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery

Published on: June 23, 2020

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...